The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients

Journal of Lipid Research

Volumn 56, Issue 3, 2015, Pages 682-691

  Song, Wei ^a   Wang, Wei ^a   Dou, Li Yang ^a   Wang, Yu ^a   Xu, Yan ^a   Chen, Lian Feng ^a   Yan, Xiao Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

ABCA1; Macrophages; Tobacco

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; CARBON MONOXIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR; NICOTINE; TAR; ABCA1 PROTEIN, HUMAN; CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MACROPHAGE; PARALLEL DESIGN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOKING CESSATION; TOBACCO DEPENDENCE; BIOSYNTHESIS; BLOOD; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SMOKING; TIME FACTOR; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATP BINDING CASSETTE TRANSPORTER 1; CELL LINE, TUMOR; CHOLESTEROL; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 84925301969     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P055491     Document Type: Article

References (44)

1. Ambrose, J. A., and R. S. Barua. 2004. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43: 1731-1737.
2. Mercado, C., and E. A. Jaimes. 2007. Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights. Curr. Hypertens. Rep. 9: 66-72.
3. Mehta, J. L. 2004. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis, Can. J. Cardiol. 20(Suppl B): 32B-36B.
4. Rios, F. J., M. Gidlund, and S. Jancar. 2011. Pivotal role for plate-let-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages. Cell. Physiol. Biochem. 27: 363-372.
5. Adorni, M. P., F. Zimetti, J. T. Billheimer, N. Wang, D. J. Rader, M. C. Phillips, and G. H. Rothblat. 2007. The roles of different pathways in the release of cholesterol from macrophages. J. Lipid Res. 48: 2453-2462.
6. Wang, X., H. L. Collins, M. Ranalletta, I. V. Fuki, J. T. Billheimer, G. H. Rothblat, A. R. Tall, and D. J. Rader. 2007. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117: 2216-2224.
7. Suetani, R. J., B. Sorrenson, J. D. Tyndall, M. J. Williams, and S. P. McCormick. 2011. Homology modeling and functional testing of an ABCA1 mutation causing Tangier disease. Atherosclerosis. 218: 404-410.
8. Patel, D. C., C. Albrecht, D. Pavitt, V. Paul, C. Pourreyron, S. P. Newman, I. F. Godsland, J. Valabhji, and D. G. Johnston. 2011. Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLoS ONE. 6: e22142.
9. Frikke-Schmidt, R., B. G. Nordestgaard, M. C. Stene, A. A. Sethi, A. T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen. 2008. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA. 299: 2524-2532.
10. Cavelier, C., L. Rohrer, and A. von Eckardstein. 2006. ATP-binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells. Circ. Res. 99: 1060-1066.
11. Mauldin, J. P., M. H. Nagelin, A. J. Wojcik, S. Srinivasan, M. D. Skafl en, C. R. Ayers, C. A. McNamara, and C. C. Hedrick. 2008. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation. 117: 2785-2792.
12. Burgess, B., K. Naus, J. Chan, V. Hirsch-Reinshagen, G. Tansley, L. Matzke, B. Chan, A. Wilkinson, J. Fan, J. Donkin, et al. 2008. Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-defi cient mice. Arterioscler. Thromb. Vasc. Biol. 28: 1731-1737.
13. Xu, Y., W. Wang, L. Zhang, L. P. Qi, L. Y. Li, L. F. Chen, Q. Fang, A. M. Dang, and X. W. Yan. 2011. A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population. Atherosclerosis. 219: 648-654.
14. Wang, X., Z. Yang, B. Xue, and H. Shi. 2011. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology. 152: 836-846.
15. Mahapatra, S. K., S. Das, S. Bhattacharjee, N. Gautam, S. Majumdar, and S. Roy. 2009. In vitro nicotine-induced oxidative stress in mice peritoneal macrophages: a dose-dependent approach. Toxicol. Mech. Methods. 19: 100-108.
16. Krause, P., E. Watzig, H. Acil, S. Konig, K. Unthan-Fechner, D. Tsikas, and I. Probst. 2010. Role of carbon monoxide and nitric oxide in adult rat hepatocytes proliferating in vitro: effects of CAS 1609. Nitric Oxide. 23: 220-226.
17. Soni, H., P. Patel, A. C. Rath, M. Jain, and A. A. Mehta. 2010. Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: role of coronary endothelium and underlying mechanism. Vascul. Pharmacol. 53: 68-76.
18. Acosta, M., A. Buchhalter, A. Breland, D. Hamilton, and T. Eissenberg. 2004. Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips. Nicotine Tob. Res. 6: 615-620.
19. Wang, W., W. Song, Y. Wang, L. Chen, and X. Yan. 2013. HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages. J. Cardiovasc. Pharmacol. 62: 90-98.
20. Zhang, J., S. Cai, B. R. Peterson, P. M. Kris-Etherton, and J. P. Heuvel. 2011. Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol. Assay Drug Dev. Technol. 9: 136-146.
21. Girdhar, G., S. Xu, J. Jesty, and D. Bluestein. 2008. In vitro model of platelet-endothelial activation due to cigarette smoke under cardiovascular circulation conditions. Ann. Biomed. Eng. 36: 1142-1151.
22. Nair, S., S. Kulkarni, H. M. Camoens, K. Ghosh, and D. Mohanty. 2001. Changes in platelet glycoprotein receptors after smoking: a flow cytometric study. Platelets. 12: 20-26.
23. Bermudez, E. A., N. Rifai, J. E. Buring, J. E. Manson, and P. M. Ridker. 2002. Relation between markers of systemic vascular inflammation and smoking in women. Am. J. Cardiol. 89: 1117-1119.
24. Berge, K. E., and T. P. Leren. 2010. Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterol. Clin. Chim. Acta. 411: 2019-2023.
25. Aiello, R. J., D. Brees, P. A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone. 2002. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22: 630-637.
26. Zhu, X., J. Y. Lee, J. M. Timmins, J. M. Brown, E. Boudyguina, A. Mulya, A. K. Gebre, M. C. Willingham, E. M. Hiltbold, N. Mishra, et al. 2008. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283: 22930-22941.
27. Nandedkar, S. D., D. Weihrauch, H. Xu, Y. Shi, T. Feroah, W. Hutchins, D. A. Rickaby, N. Duzgunes, C. A. Hillery, K. S. Konduri, et al. 2011. D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma. J. Lipid Res. 52: 499-508.
28. Sticozzi, C., A. Pecorelli, G. Belmonte, and G. Valacchi. 2010. Cigarette smoke affects ABCAl expression via liver X receptor nuclear translocation in human keratinocytes 2. Int. J. Mol. Sci. 11: 3375-3386.
29. Okoli, C. T., T. Kelly, and E. J. Hahn. 2007. Secondhand smoke and nicotine exposure: a brief review. Addict. Behav. 32: 1977-1988.
30. Craig, W. Y., G. E. Palomaki, and J. E. Haddow. 1989. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 298: 784-788.
31. Fitzgerald, M. L., Z. Mujawar, and N. Tamehiro. 2010. ABC transporters, atherosclerosis and inflammation. Atherosclerosis. 211: 361-370.
32. Haghpassand, M., P. A. Bourassa, O. L. Francone, and R. J. Aiello. 2001. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108: 1315-1320.
33. Ye, D., B. Lammers, Y. Zhao, I. Meurs, T. J. Van Berkel, and E. M. Van. 2011. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Curr. Drug Targets. 12: 647-660.
34. Mehrabi, M. R., T. Thalhammer, P. Haslmayer, H. D. Glogar, G. Wieselthaler, S. Humpeler, W. Marktl, and C. Ekmekcioglu. 2002. The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles. Biomed. Pharmacother. 56: 407-410.
35. Schmitz, G., and T. Langmann. 2005. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim. Biophys. Acta. 1735: 1-19.
36. Ozasa, H., M. Ayaori, M. Iizuka, Y. Terao, H. Uto-Kondo, E. Yakushiji, S. Takiguchi, K. Nakaya, T. Hisada, Y. Uehara, et al. 2011. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/LXRalpha pathway: findings from in vitro and ex vivo studies. Atherosclerosis. 219: 141-150.
37. Stone, K. K., E. Bermudez, and W. A. Pryor. 1994. Aqueous extracts of cigarette tar containing the tar free radical cause DNA nicks in mammalian cells. Environ. Health Perspect. 102 (Suppl 10): 173-178.
38. Pryor, W. A., K. Stone, L. Y. Zang, and E. Bermudez. 1998. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem. Res. Toxicol. 11: 441-448.
39. Guzik, K., J. Skret, J. Smagur, M. Bzowska, B. Gajkowska, D. A. Scott, and J. S. Potempa. 2011. Cigarette smoke-exposed neutrophils die unconventionally but are rapidly phagocytosed by macrophages. Cell Death Dis. 2: e131.
40. Isaac, P. F., and M. J. Rand. 1972. Cigarette smoking and plasma levels of nicotine. Nature. 236: 308-310.
41. Yoshikawa, H., M. Kurokawa, N. Ozaki, K. Nara, K. Atou, E. Takada, H. Kamochi, and N. Suzuki. 2006. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin. Exp. Immunol. 146: 116-123.
42. Sun, Y. P., B. Q. Zhu, A. E. Browne, R. E. Sievers, J. M. Bekker, K. Chatterjee, W. W. Parmley, and S. A. Glantz. 2001. Nicotine does not influence arterial lipid deposits in rabbits exposed to secondhand smoke. Circulation. 104: 810-814.
43. Sari, I., S. Zengin, O. Ozer, V. Davutoglu, C. Yildirim, and M. Aksoy. 2008. Chronic carbon monoxide exposure increases electrocardiographic P-wave and QT dispersion. Inhal. Toxicol. 20: 879-884.
44. Goniewicz, M. L., J. Czogala, L. Kosmider, B. Koszowski, W. Zielinska-Danch, and A. Sobczak. 2009. Exposure to carbon monoxide from second-hand tobacco smoke in Polish pubs. Cent. Eur. J. Public Health. 17: 220-222.